Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116

ABC Transporters: From Microorganisms to Man

Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985

Antibiotics in Laboratory Medicine.

Lorian, V. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,809

The mechanism of action of cyclosporin A and FK506

Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127

Isogenic strain construction and gene mapping in Candida albicans.

Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695

Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990

Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039

Amphotericin B: 30 Years of Clinical Experience

Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,013

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

Fruman, D. A., Klee, C. B., Bierer, B. E., & Burakoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3686 · Cited by 823

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784

Combination antifungal therapy

Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541

Antifungal Resistance and New Strategies to Control Fungal Infections

Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531

A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2 , Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans

Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385

Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence

Sanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350

Calcineurin is essential for survival during membrane stress in Candida albicans

Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342

Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.

Steinbach, W. J., Reedy, J. L., Cramer, R. A., Perfect, J. R., & Heitman, J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1680 · Cited by 313

Antifungal drug resistance to azoles and polyenes

Canuto, M. M., & Rodero, F. G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00371-7 · Cited by 310

Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285

Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270

Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans , Candida glabrata , and Candida krusei

Onyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282

CRZ1 , a target of the calcineurin pathway in Candida albicans

Karababa, M., Valentino, E., Pardini, G., Coste, A. T., Bille, J., & Sanglard, D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05037.x · Cited by 231

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal

Costa-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms

Uppuluri, P., Nett, J., Heitman, J., & Andes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-07 · Cited by 228

Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence

Blankenship, J. R., Wormley, F. L., Boyce, M. K., Schell, W. A., Filler, S. G., Perfect, J. R., & Heitman, J. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.3.422-430.2003 · Cited by 186

Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters

Nakamura, K., Niimi, M., Niimi, K., Holmes, A. R., Yates, J. E., Decottignies, A., Monk, B. C., Goffeau, A., & Cannon, R. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3366-3374.2001 · Cited by 185

Mitogen-activated Protein Kinase Stimulation of Ca2+Signaling Is Required for Survival of Endoplasmic Reticulum Stress in Yeast

Bonilla, M., & Cunningham, K. W. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0113 · Cited by 165

Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms

Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165

Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms

Khan, M. S., & Ahmad, I. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr512 · Cited by 162

Combinations of antifungal agents in therapy–what value are they?

Cuenca‐Estrella, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh434 · Cited by 162

Mode of Selection and Experimental Evolution of Antifungal Drug Resistance in Saccharomyces cerevisiae

Anderson, J. B., Sirjusingh, C., Parsons, A. B., Boone, C., Wickens, C., Cowen, L. E., & Kohn, L. M. (2003) · Genetics · doi:10.1093/genetics/163.4.1287 · Cited by 156

In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus

Steinbach, W. J., Schell, W. A., Blankenship, J. R., Onyewu, C., Heitman, J., & Perfect, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1664-1669.2004 · Cited by 135

Calcineurin Is Essential for Virulence in Candida albicans

Bader, T., Bodendorfer, B., Schröppel, K., & Morschhäuser, J. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5344-5354.2003 · Cited by 121

The Calcineurin Target, Crz1, Functions in Azole Tolerance but Is Not Required for Virulence of Candida albicans

Onyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121

Acidic calcium stores of Saccharomyces cerevisiae

Cunningham, K. W. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.01.010 · Cited by 120

Defining the frontiers between antifungal resistance, tolerance and the concept of persistence

Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118

Calcineurin as a multifunctional regulator: Unraveling novel functions in fungal stress responses, hyphal growth, drug resistance, and pathogenesis

Juvvadi, P. R., Lamoth, F., & Steinbach, W. J. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.02.004 · Cited by 116

Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a d -Octapeptide Derivative

Niimi, K., Harding, D. R. K., Parshot, R., King, A., Lun, D. J., Decottignies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1256-1271.2004 · Cited by 115

Calcineurin Is Required forCandida albicansTo Survive Calcium Stress in Serum

Blankenship, J. R., & Heitman, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5767-5774.2005 · Cited by 111

pH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies

Cornet, M., & Gaillardin, C. M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 101

Treatment options of invasive fungal infections in adults

Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 90

Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis

Murphy, S. E., & Bicanic, T. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 86

Domain Architecture of the Regulators of Calcineurin (RCANs) and Identification of a Divergent RCAN in Yeast

Mehta, S., Li, H., Hogan, P. G., & Cunningham, K. W. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01197-08 · Cited by 83

Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence

Pascon, R. C., Ganous, T. M., Kingsbury, J. M., Cox, G. M., & McCusker, J. H. (2004) · Microbiology · doi:10.1099/mic.0.27235-0 · Cited by 83

Fungal endocarditis

Nadir, E., & Rubinstein, E. (2004) · Current Infectious Disease Reports · doi:10.1007/s11908-004-0048-8 · Cited by 77

Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence

Reedy, J. L., Filler, S. G., & Heitman, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.09.002 · Cited by 76

Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium

Tanabe, K., Lamping, E., Adachi, K., Takano, Y., Kawabata, K., Shizuri, Y., Niimi, M., & Uehara, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.110 · Cited by 74

Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance

Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69

Drug repurposing strategies in the development of potential antifungal agents

Zhang, Q., Liu, F., Zeng, M., Xin, C., Zhang, J., Mao, Y., & Song, Z. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11407-7 · Cited by 76

Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans

Chen, Y., Lehman, V. N., Averette, A. F., Perfect, J. R., & Heitman, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057672 · Cited by 69

In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients

Steinbach, W. J., Singh, N., Miller, J. L., Benjamin, D. K., Schell, W. A., Heitman, J., & Perfect, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4922-4925.2004 · Cited by 66

Antifungal Activity of Nonantifungal Drugs

Afeltra, J., & Verweij, P. E. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0947-x · Cited by 63

Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity

Wall, G., & Lopez-Ribot, J. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00924-20 · Cited by 67

Reverse Genetics in Candida albicans Predicts ARF Cycling Is Essential for Drug Resistance and Virulence

Epp, E., Vanier, G., Harcus, D., Lee, A. Y., Jansen, G., Hallett, M., Sheppard, D. C., Thomas, D. Y., Munro, C. A., Mullick, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000753 · Cited by 61

Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump

Guo, X.-L., Leng, P., Yang, Y., Yu, L., & Lou, H. (2008) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03617.x · Cited by 61

In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves

Li, Y., Sun, S., Guo, Q., Ma, L., Shi, C., Su, L., & Li, H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm493 · Cited by 61

Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1 , CDR2 , CaMDR1 , and FLU1 Genes

Marchetti, O., Moreillon, P., Entenza, J. M., Vouillamoz, J., Glauser, M. P., Billé, J., & Sanglard, D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1565-1570.2003 · Cited by 58

Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole

Afeltra, J., Vitale, R. G., Mouton, J. W., & Verweij, P. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1335-1343.2004 · Cited by 56

A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs

Kim, J., Cho, Y.-J., Do, E., Choi, J., Hu, G., Cadieux, B., Chun, J., Lee, Y., Kronstad, J. W., & Jung, W. H. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.08.006 · Cited by 53

In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes

Dannaoui, É., Schwarz, P., & Lortholary, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00184-09 · Cited by 54

Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients1

Singh, N., & Heitman, J. (2004) · Transplantation · doi:10.1097/01.tp.0000117252.75651.d6 · Cited by 50

Mechanism of Action of Tetrandrine, a Natural Inhibitor of Candida albicans Drug Efflux Pumps

Zhang, H., Gao, A., Li, F., Zhang, G., Hon In, H. O., & Liao, W. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.623 · Cited by 49

Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target

Li, W., Shrivastava, M., Lu, H., & Jiang, Y. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126786 · Cited by 47

Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux

Saini, P., Prasad, T., Gaur, N. A., Shukla, S., Jha, S., Komath, S. S., Khan, L. A., Haq, Q. M. R., & Prasad, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki183 · Cited by 47

Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species

Chen, S. C.-A., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Virulence · doi:10.4161/viru.2.4.16764 · Cited by 41

High-Throughput Nano-Biofilm Microarray for Antifungal Drug Discovery

Srinivasan, A., Leung, K. P., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · mBio · doi:10.1128/mbio.00331-13 · Cited by 41

Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections

Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40

Calcium homeostasis and signaling in fungi and their relevance forpathogenicity of yeasts and filamentous fungi

Tisi, R., Rigamonti, M. M., Groppi, S., & Belotti, F. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.4.505 · Cited by 41

Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers

Brings, A., Lehmann, M., Foerster, K. I., Burhenne, J., Weiß, J., Haefeli, W. E., & Czock, D. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13934 · Cited by 40

Insights on the anticandidal activity of non-antifungal drugs

Moraes, D. C., & Ferreira-Pereira, A. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.004 · Cited by 37

Combination antifungal therapy againstCandidaspecies: the new frontier-are we there yet?

Vázquez, J. A. (2003) · Medical Mycology · doi:10.1080/13693780310001616528 · Cited by 36

Neonatal Coinfection Model of Coagulase-Negative Staphylococcus ( Staphylococcus epidermidis ) and Candida albicans : Fluconazole Prophylaxis Enhances Survival and Growth

Pammi, M., Pham, D., Fein, M., Kong, L., & Weisman, L. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01298-06 · Cited by 34

Signaling cascades as drug targets in model and pathogenic fungi.

Bastidas, R. J., Reedy, J. L., Morales-Johansson, H., Heitman, J., & Cardenas, M. E. (2008) · PubMed · Cited by 34

Dissecting the Roles of the Calcineurin Pathway in Unisexual Reproduction, Stress Responses, and Virulence in Cryptococcus deneoformans

Fu, C., Donadio, N., Cardenas, M. E., & Heitman, J. (2017) · Genetics · doi:10.1534/genetics.117.300422 · Cited by 33

Resistance and tolerance mechanisms to antifungal drugs in fungal pathogens

Sanglard, D. (2003) · Mycologist · doi:10.1017/s0269915x03002076 · Cited by 29

Astemizole and an analogue promote fungicidal activity of fluconazole againstCryptococcus neoformansvar.grubiiandCryptococcus gattii

Vu, K., & Gelli, A. (2010) · Medical Mycology · doi:10.3109/13693780903081968 · Cited by 28

Combination antifungal therapy: a strategy for the management of invasive fungal infections.

Carrillo-Muñoz, A. J., Finquelievich, J. L., Tur‐Tur, C., Eraso, E., Jauregizar, N., Quindós, G., & Giusiano, G. (2014) · PubMed · Cited by 29

Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp

Tits, J., Cools, F., Cremer, K. D., Brucker, K. D., Berman, J. G., Verbruggen, K., Gevaert, B., Cos, P., Cammue, B. P. A., & Thevissen, K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01296-20 · Cited by 27

Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis

Wang, Y., Jia, X., Jia, J., Li, M., Cao, Y., Gao, P., Liao, W., Cao, Y., & Jiang, Y. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05187.x · Cited by 26

Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520

Shukla, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh308 · Cited by 25

Antifungal activity of immunosuppressants used alone or in combination with fluconazole

Zhang, M., Yang, X., Wang, D., Yu, C., & Sun, S. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14126 · Cited by 24

Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function

Tanabe, K., Lamping, E., Nagi, M., Okawada, A., Holmes, A. R., Miyazaki, Y., Cannon, R. D., Monk, B. C., & Niimi, M. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07820.x · Cited by 24

Targeting the Calcineurin Pathway Enhances Ergosterol Biosynthesis Inhibitors against Trichophyton mentagrophytes In Vitro and in a Human Skin Infection Model

Onyewu, C., Eads, E., Schell, W. A., Perfect, J. R., Ullmann, Y., Kaufman, G., Horwitz, B. A., Berdicevsky, I., & Heitman, J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00492-07 · Cited by 23

Calcineurin-dependent contributions to fitness in the opportunistic pathogen Candida glabrata

Pavesic, M. W., Gale, A. N., Nickels, T. J., Harrington, A. A., Bussey, M., & Cunningham, K. W. (2024) · mSphere · doi:10.1128/msphere.00554-23 · Cited by 22

In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales

Schwarz, P., Schwarz, P., Felske-Zech, H., & Dannaoui, É. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz102 · Cited by 22

Role of Ca2+/Calmodulin Signaling Pathway on Morphological Development of Candida albicans

Sato, T., Ueno, Y., Watanabe, T., Mikami, T., & Matsumoto, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1281 · Cited by 22

Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches

Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20

Calcium-activated-calcineurin reduces the in vitro and in vivo sensitivity of fluconazole to Candida albicans via Rta2p

Jia, Y., Tang, R.-J., Wang, L., Zhang, X., Wang, Y., Jia, X.-M., & Jiang, Y.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048369 · Cited by 19

Molecular Principles of Antifungal Drug Resistance

Sanglard, D., & White, T. C. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch14 · Cited by 19

The activity ofRTA2,a downstream effector of the calcineurin pathway, is required during tunicamycin-induced ER stress response inCandida albicans

Thomas, E., Sircaik, S., Román, E., Brunel, J. M., Johri, A. K., Plá, J., & Panwar, S. L. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov095 · Cited by 18

Antifungal therapy - state of the art at the beginning of the 21st century

Polak, A. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7974-3_4 · Cited by 19

Immunotherapy with Tacrolimus (FK506) Does Not Select for Resistance to Calcineurin Inhibitors inCandida albicansIsolates from Liver Transplant Patients

Reedy, J. L., Husain, S., Ison, M. G., Pruett, T. L., Singh, N., & Heitman, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1573-1577.2006 · Cited by 18

Status of combination therapy for refractory mycoses

Antoniadou, A., & Kontoyiannis, D. P. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00005 · Cited by 17

Structural design of microbicidal cationic oligomers and their synergistic interaction with azoles against Candida albicans

Yuan, Y., Zhou, F., Su, H., & Zhang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-48322-x · Cited by 16

In Vitro Interactions of Calcineurin Inhibitors with Conventional Antifungal Agents Against the Yeast Form of Penicillium marneffei

Mo, D., Li, X., Wei, L., Sun, C., Liang, H., & Cao, C. (2014) · Mycopathologia · doi:10.1007/s11046-014-9787-8 · Cited by 16

Kch1 Family Proteins Mediate Essential Responses to Endoplasmic Reticulum Stresses in the Yeasts Saccharomyces cerevisiae and Candida albicans

Stefan, C. P., & Cunningham, K. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508705 · Cited by 15

Effects of calcineurin inhibitors, cyclosporine A and tacrolimus (FK506), on the activity of antifungal drugs against Candida spp.

Şen, S., Kiraz, N., Barış, A., Turan, D., Öz, Y., Dağ, İ., & Aygün, G. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001354 · Cited by 13

Molecular targeted treatments for fungal infections: the role of drug combinations

Lupetti, A., Nibbering, P. H., Campa, M., Tacca, M. D., & Danesi, R. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00091-1 · Cited by 13

Antifungal Activity of the Ethanol Extract from Flos Rosae Chinensis with Activity against Fluconazole‐Resistant Clinical Candida

Zhang, L., Lin, H., Liu, W. Y., Dai, B., Yan, L., Cao, Y., & Jiang, Y.-Y. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/4780746 · Cited by 12

Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.

Wibawa, T., Nurrokhman, Baly, I., Daeli, P. R., Kartasasmita, G., & Wijayanti, N. (2015) · PubMed · Cited by 11

Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis

Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0195-9 · Cited by 10

A Calcineurin Regulator MoRCN1 Is Important for Asexual Development, Stress Response, and Plant Infection of Magnaporthe oryzae

Liu, C., Liu, T., Lv, Z., Qin, M., Qu, Z., Zhang, Z., Li, F., Chen, D., Zhang, X., Chen, X., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.925645 · Cited by 8

Pharmacotherapy of Candida bloodstream infections: new treatment options, new era

Lewis, R. E. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1039 · Cited by 8

Immunosuppression in the Management of Presumed Non-infective Uveitis; Are We Sure What We are Treating? Notes on the Antimicrobial Properties of the Systemic Immunosuppressants

Jones, N. P. (2019) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2019.1643030 · Cited by 7

MINIREVIEW Combination Antifungal Therapy

Johnson, J. R., Dougall, C. M., & Zeichner, L. O. (2004) · Cited by 7

Cyclosporin A Treatment and Decreased Fungal Load/Antigenemia in Experimental Murine Paracoccidioidomycosis

Massuda, T. Y. C., Nagashima, L. A., Leonello, P. C., Kaminami, M. S., Mantovani, M. S., Sano, A., Uno, J., Venâncio, E. J., Camargo, Z. P. D., & Itano, E. N. (2010) · Mycopathologia · doi:10.1007/s11046-010-9359-5 · Cited by 6

Antifungal Drug Resistance: Pumps and Permutations

White, T. C., Harry, J. B., & Oliver, B. G. G. (2004) · Springer eBooks · doi:10.1007/978-3-662-10380-7_17 · Cited by 5

Mechanisms and clinical significance of antifungal resistance

Billé, J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00260-0 · Cited by 5

Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata

Harrington, A. A., Nickels, T. J., & Cunningham, K. W. (2026) · mBio · doi:10.1128/mbio.02546-25 · Cited by 4

Current and emerging therapies for fungal biofilms and systemic infections

Elgammal, Y., Martinez, R. I. G., Requejo, A., & Martinez, L. R. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2570185 · Cited by 4

Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans

Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., & Sanglard, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2373-2381.2000 · Cited by 252

Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans

Louie, A., Liu, W., Miller, D. A., Sucke, A. C., Liu, Q., Drusano, G. L., Mayers, M., & Miller, M. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2831 · Cited by 73

Susceptibility of 35 Candida strains to fluconazole and in vitro effects in coordination of the fluconazole and cyclosporin

Chen, B. (2006) · The Chinese Journal of Clinical Pharmacology

Effecacies of high-dose fluconazole plus amphotericin B and highdose fluconazole plus 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans

Louie, A. K. (1999) · Cited by 4

Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis

Witt, M. D., & Bayer, A. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2481 · Cited by 29